Morris Wheeler

Founder and Principal

1996 - Current

Drummond Road Capital, was one of 2014's 50 most active Seed Investors according to CBI Insights. It has also received accolades from Mattermark for its investment activity. DR is the manager of Clarion Direct Investment a investment partnership investing in Private Equity, Venture Capital and other direct investments. Through Drummond Road, Mr. Wheeler also serves as the Chief Investment Officer of Clarion Capital LLC.

Member

2021

Founder and Managing Member

2009

Venture Capital, Private Equity and Real Estate arm of Clarion Capital Limited. Founder friendly focus on entrepreneurs in national accelerators. Actively working with TechStars, 500Startups, Y-Combinator, the Brandery, LaunchPad LA, LaunchHouse, FlashStarts, Bizdom. Portfolio investments include, Revolve, AventuraHQ, Keen.io, MobiPlug, Aha!ogy, DivShot, Tagsauris, ExpenseBot, Tred, Tackk. Nimble, Learning Egg, Wanderu.

Managing Member and Chief Investment Officer

2011

Clarion Capital LLC is a diverse investment partnership that maintains commingled asset pools designed to allow an investor to maintain proper asset allocations and diversification across all asset classes

Senior Advisor

2022

Chairman of Finance and Investment Committee

2021

Lead Mentor

2014

Privileged to serve as advisor to companies accepted into one of the top rated accelerators in the world

Executive Chairman

2019 - 2021

The Versaflex Companies are a private equity led family of specialty coating solutions across an array of markets and industries. Companies include Versaflex, SPI, Raven Lining Systems, Milamar Coatings, Bridge Preservation and Vanberg Specialized Coatings. Sold to PPG in February 2021

Operating Partner

2018 - 2021

Following acquisition of Cohesant by Dalfort portfolio platform Versaflex, I joined Dalfort as one of its operating partners to focus on the combined entity and serve as Dalfort's appointee to the Versaflex board.

Board Member

2013 - 2020

SaaS virtual engagement and communications tool that connects life science companies with physicians, nurses, payers and patients. 100mm growth equity financing secured from Insight Partners in September 2020.